Follow the Spago Nanomedical AB (publ) stock price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Spago Nanomedical AB (publ) has recorded 15 reports. Market capitalisation: €93.4m. The latest transaction was reported on 22 June 2026 (Purchase). Among the most active insiders: Peter Lindell. All data is accessible without an account.
15
Insider Decl.
0
Thresholds
€1m
15 ops.
Buy Volume
·
0 ops.
Sell Volume
31Σ signal
Buys €1m· Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
100,000 shares@ SEK 0.001100.0% of flowTeckningsrätt/UniträttFI:A003Z769-1
Ideal exit: 6 Mar 2027 (T+270)
15 of 15 declarations
About Spago Nanomedical AB (publ)
Spago Nanomedical AB (publ) is a Swedish company focused on developing targeted treatments for cancer. It is listed on the Stockholm Stock Exchange (XSTO).